[HTML][HTML] Current advances in 3D bioprinting for cancer modeling and personalized medicine
N Germain, M Dhayer, S Dekiouk… - International journal of …, 2022 - mdpi.com
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
N Germain, M Dhayer, S Dekiouk… - International Journal of …, 2022 - search.proquest.com
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine.
N Germain, M Dhayer, S Dekiouk… - … Journal of Molecular …, 2022 - search.ebscohost.com
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
N Germain, M Dhayer, S Dekiouk… - International Journal of …, 2022 - hal.science
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
[HTML][HTML] Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
N Germain, M Dhayer, S Dekiouk… - International Journal of …, 2022 - ncbi.nlm.nih.gov
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine.
N Germain, M Dhayer, S Dekiouk… - International Journal of …, 2022 - europepmc.org
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
N Germain, M Dhayer, S Dekiouk, P Marchetti - 2022 - agris.fao.org
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
[PDF][PDF] Current advances in 3D bioprinting for cancer modeling and personalized medicine
N Germain, M Dhayer, S Dekiouk, P Marchetti - 2022 - researchgate.net
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
N Germain, M Dhayer, S Dekiouk… - … journal of molecular …, 2022 - pubmed.ncbi.nlm.nih.gov
Tumor cells evolve in a complex and heterogeneous environment composed of different cell
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
types and an extracellular matrix. Current 2D culture methods are very limited in their ability …
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
N Germain, M Dhayer, S Dekiouk, P Marchetti - 2022 - lilloa.univ-lille.fr
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine Toggle
navigation English français Aide | Contact | À Propos | Ouvrir une session Portail HAL | Pages …
navigation English français Aide | Contact | À Propos | Ouvrir une session Portail HAL | Pages …